Update on the Safety and Efficacy of JAK Inhibitor Therapeutics for the Treatment of Atopic Dermatitis

Apr 30, 2022

- Apr 29, 2023

1.75

Claim your AMA PRA Category 1 Credit(s)

This course is available for logged in users only. Please login or register to take the course.

Obstructive Hypertrophic Cardiomyopathy: Evidence-Based, Specific Pathology-Targeted Manag...

LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”

MANAGEMENT OF PSVT: UPDATE FROM ACC25